Linagliptin: a new interesting molecule in therapy of type 2 diabetes mellitus

Abstract

Incretin-based therapy of type 2 diabetes mellitus represents a preferred therapeutic option in many patients owing to its positive matabolic effects. The aim of this paper is to review clinical effects of linagliptin and its position in the current type 2 diabetes mellitus treatment algorithm.

Keywords

• Diabetes mellitus
• linagliptin
• liver insufficiency